These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
757 related articles for article (PubMed ID: 20096135)
1. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker. Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135 [TBL] [Abstract][Full Text] [Related]
2. Annexin A1: A new immunohistological marker of cholangiocarcinoma. Hongsrichan N; Rucksaken R; Chamgramol Y; Pinlaor P; Techasen A; Yongvanit P; Khuntikeo N; Pairojkul C; Pinlaor S World J Gastroenterol; 2013 Apr; 19(16):2456-65. PubMed ID: 23674846 [TBL] [Abstract][Full Text] [Related]
3. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma. Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773 [TBL] [Abstract][Full Text] [Related]
4. Periostin activates integrin α5β1 through a PI3K/AKT‑dependent pathway in invasion of cholangiocarcinoma. Utispan K; Sonongbua J; Thuwajit P; Chau-In S; Pairojkul C; Wongkham S; Thuwajit C Int J Oncol; 2012 Sep; 41(3):1110-8. PubMed ID: 22735632 [TBL] [Abstract][Full Text] [Related]
5. Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma. Chuaysri C; Thuwajit P; Paupairoj A; Chau-In S; Suthiphongchai T; Thuwajit C Oncol Rep; 2009 Apr; 21(4):957-69. PubMed ID: 19287994 [TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma. Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b. Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763 [TBL] [Abstract][Full Text] [Related]
8. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma. Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137 [TBL] [Abstract][Full Text] [Related]
9. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma. Obchoei S; Weakley SM; Wongkham S; Wongkham C; Sawanyawisuth K; Yao Q; Chen C Mol Cancer; 2011 Aug; 10():102. PubMed ID: 21871105 [TBL] [Abstract][Full Text] [Related]
10. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells. Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065 [TBL] [Abstract][Full Text] [Related]
11. Progenitor gene DLK1 might be an independent prognostic factor of liver cancer. Jin ZH; Yang RJ; Dong B; Xing BC Expert Opin Biol Ther; 2008 Apr; 8(4):371-7. PubMed ID: 18352842 [TBL] [Abstract][Full Text] [Related]
12. Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines. Yang J; Sontag D; Gong Y; Minuk GY Ann Hepatol; 2021; 21():100265. PubMed ID: 33045415 [TBL] [Abstract][Full Text] [Related]
13. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma. Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932 [TBL] [Abstract][Full Text] [Related]
14. Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma. Kosriwong K; Menheniott TR; Giraud AS; Jearanaikoon P; Sripa B; Limpaiboon T World J Gastroenterol; 2011 Mar; 17(12):1631-41. PubMed ID: 21472131 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway. Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X Gene; 2019 May; 698():50-60. PubMed ID: 30822475 [TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma. Xu YF; Yang XQ; Lu XF; Guo S; Liu Y; Iqbal M; Ning SL; Yang H; Suo N; Chen YX Biochem Biophys Res Commun; 2014 Mar; 446(1):54-60. PubMed ID: 24565842 [TBL] [Abstract][Full Text] [Related]
17. The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells. Utaijaratrasmi P; Vaeteewoottacharn K; Tsunematsu T; Jamjantra P; Wongkham S; Pairojkul C; Khuntikeo N; Ishimaru N; Sirivatanauksorn Y; Pongpaibul A; Thuwajit P; Thuwajit C; Kudo Y Mol Cancer; 2018 Jan; 17(1):10. PubMed ID: 29347950 [TBL] [Abstract][Full Text] [Related]
18. Revealing the role of necroptosis microenvironment: FCGBP + tumor-associated macrophages drive primary liver cancer differentiation towards cHCC-CCA or iCCA. Wang C; Chen C; Hu W; Tao L; Chen J Apoptosis; 2024 Apr; 29(3-4):460-481. PubMed ID: 38017206 [TBL] [Abstract][Full Text] [Related]
19. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion. Zhou Z; Ma J Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases. Laohaviroj M; Chamgramol Y; Pairojkul C; Mulvenna J; Sripa B Asian Pac J Cancer Prev; 2016; 17(1):201-5. PubMed ID: 26838210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]